- Home
- EPRT vs BPMC Comparison
EPRT vs BPMC Comparison
Compare EPRT & BPMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPRT
- BPMC
- Stock Information
- Founded
- EPRT 2016
- BPMC 2008
- Country
- EPRT United States
- BPMC United States
- Employees
- EPRT N/A
- BPMC N/A
- Industry
- EPRT Real Estate Investment Trusts
- BPMC Biotechnology: Pharmaceutical Preparations
- Sector
- EPRT Real Estate
- BPMC Health Care
- Exchange
- EPRT Nasdaq
- BPMC Nasdaq
- Market Cap
- EPRT 6.0B
- BPMC 5.8B
- IPO Year
- EPRT 2018
- BPMC 2015
- Fundamental
- Price
- EPRT $32.16
- BPMC $97.17
- Analyst Decision
- EPRT Buy
- BPMC Buy
- Analyst Count
- EPRT 14
- BPMC 21
- Target Price
- EPRT $34.84
- BPMC $124.05
- AVG Volume (30 Days)
- EPRT 1.5M
- BPMC 988.9K
- Earning Date
- EPRT 04-23-2025
- BPMC 05-01-2025
- Dividend Yield
- EPRT 3.67%
- BPMC N/A
- EPS Growth
- EPRT N/A
- BPMC N/A
- EPS
- EPRT 1.16
- BPMC N/A
- Revenue
- EPRT $475,463,000.00
- BPMC $562,121,000.00
- Revenue This Year
- EPRT $19.43
- BPMC $44.85
- Revenue Next Year
- EPRT $17.18
- BPMC $32.06
- P/E Ratio
- EPRT $27.68
- BPMC N/A
- Revenue Growth
- EPRT 25.32
- BPMC 99.19
- 52 Week Low
- EPRT $26.07
- BPMC $73.04
- 52 Week High
- EPRT $34.88
- BPMC $121.90
- Technical
- Relative Strength Index (RSI)
- EPRT 54.98
- BPMC 59.54
- Support Level
- EPRT $31.52
- BPMC $87.03
- Resistance Level
- EPRT $32.35
- BPMC $104.86
- Average True Range (ATR)
- EPRT 0.62
- BPMC 3.86
- MACD
- EPRT 0.03
- BPMC 1.24
- Stochastic Oscillator
- EPRT 65.77
- BPMC 64.38
About EPRT Essential Properties Realty Trust Inc.
Essential Properties Realty Trust Inc is a real estate investment trust. It is an internally managed real estate company acquires, owns and manages single-tenant properties that are net leased on a long-term basis to middle-market companies operating service-oriented or experience-based businesses. The Company generally invests in and leases freestanding, single-tenant commercial real estate facilities where a tenant services its customers and conducts activities that are essential to the generation of the tenant's sales and profits.
About BPMC Blueprint Medicines Corporation
Blueprint Medicines Corp is a biopharmaceutical company. It is focused on improving the lives of patients with diseases driven by abnormal kinase activation. The company has developed a small molecule drug pipeline in cancer and a rare genetic disease. Its drug candidates includes AYVAKIT for the treatment of systemic mastocytosis, BLU-808 a potential treatment for mast cell disorders, including chronic urticaria, sleep disruption and other related diseases. It also has other drugs in its pipeline such as BLU-956, BLU-222 for treatment of breast cancer.